A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject

NCT04041544 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: SN1011
DRUG: SN1011 placebo

Sponsor

SinoMab BioScience Ltd